2017

02/03/2017 Integragen announces successfull completion of a € 3.7 million capital increase
01/09/2017 IntegraGen Reports Sharp Increase in Sales in 2016

2016

10/14/2016 IntegraGen Reports Revenues for First Half of 2016
10/10/2016 New Data on IntegraGen’s miR-31-3p Biomarker Featured in Presentation at 2016 ESMO Congress
07/07/2016 IntegraGen reports strong revenue growth during first half of 2016
06/29/2016 AP-HP and IntegraGen Agree to a Research Partnership to Develop a Common Platform for High-Throughput Sequencing
06/06/2016 IntegraGen Presents Positive Data at 2016 ASCO Meeting on the Role of microRNA Biomarker miR-31-3p
04/08/2016 IntegraGen Announces 2015 Financial Results
01/14/2016 IntegraGen Reports 2015 Revenue

2015

12/02/2015 IntegraGen Collaborating with FIRE-3 Clinical Trial Investigators to Study hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker
11/17/2015 Gustave Roussy and IntegraGen announce completion of one thousand analyses on clinical research sequencing platform
10/02/2015 IntegraGen announces H1 2015 results
08/25/2015 IntegraGen sequencing of 193 liver tumor exomes published in Nature Genetics
07/10/2015 IntegraGen Reports Revenue for First Half of 2015
07/08/2015 AP-HP: Georges Pompidou European Hospital and IntegraGen sign agreement
06/01/2015 IntegraGen presents positive data from two new studies on miR-31-3p biomarker at ASCO 2015
04/10/2015 IntegraGen Announces 2014 Financial Results
03/24/2015 The Institut Pasteur Announces an Alliance with IntegraGen to Strengthen its High-Throughput Sequencing Activities in Microbiology
02/05/2015 IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test

2014

12/16/2014 IntegraGen Collaborating with PICCOLO Study Investigators to Validate Hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker
12/02/2014 IntegraGen Obtains Exclusive Worldwide License for Two Molecular Signatures for Patients with Liver Cancer
10/07/2014 IntegraGen Reports First Half 2014 Financial Results
09/30/2014 IntegraGen Presents Data at ESMO 2014 Confirming that its microRNA Biomarker Predicts Survival in Patients with Metastatic Colorectal Cancer
09/02/2014 IntegraGen Announces Collaboration with the French Intergroup of Thoracic Oncology (IFCT)
to Explore the Role of miR‐31‐3p Biomarker in Non‐Small Cell Lung Cancer
06/23/2014 IntegraGen, Gustave Roussy, INSERM and Sogeti High Tech Announce Collaborative Development of an Advanced Scientific Software Program to Assist with the Interpretation of Genome Sequencing Data for Cancer Patients
06/02/2014 IntegraGen Presents Data at ASCO 2014 Annual Meeting on microRNA Biomarker Which Predicts Outcomes in Metastatic Colorectal Cancer Patients
05/19/2014 IntegraGen Presents Data on New Version of the ARISk® Test during the 13th Annual Meeting for Autism Research
05/15/2014 IntegraGen Announces Publication of Study with Biomarker Associated with Survival in Metastatic Colorectal Cancer Patients Treated with Drug Therapy
04/11/2014 IntegraGen Announces 2013 Annual Results
04/03/2014 IntegraGen Announces Collaborative Agreement with Pfizer to Evaluate IntegraGen’s Proprietary Hepatocellular Carcinoma Molecular Signature
03/24/2014 IntegraGen and Gustave Roussy Announce the Set-up of a High-Throughput Clinical Sequencing Unit
02/21/2014 IntegraGen Announces Publication of Study Which Supports the Association of Common Genetic Variants in the Development of Autism
01/14/2014 IntegraGen Collaborating with New EPOC Study Investigators to Validate Metastatic Colorectal Cancer Biomarker

Archived Press Releases 2013 / 2012